cyclin-dependent kinase inhibitor 1A (P21) ; Mus musculus






987 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1321333 Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol 1992 Aug 6
2 1323817 smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells. Oncogene 1992 Sep 1
3 1328223 Activation of Ras by insulin in 3T3 L1 cells does not involve GTPase-activating protein phosphorylation. J Biol Chem 1992 Oct 15 2
4 1542698 Evidence that the ras oncogene-encoded p21 protein induces oocyte maturation via activation of protein kinase C. Proc Natl Acad Sci U S A 1992 Mar 1 2
5 1554410 Induction and progression of the transformed phenotype in cloned rat embryo fibroblast cells: studies employing type 5 adenovirus and wild-type and mutant Ha-ras oncogenes. Mol Carcinog 1992 2
6 1577615 Synthesis, characterization and biodistribution of tris(beta-diketonato)technetium(III) complexes. Int J Rad Appl Instrum B 1992 Jan 2
7 1714463 Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C. J Cell Biol 1991 Aug 2
8 1730682 Transforming and c-fos promoter/enhancer-stimulating activities of a stimulatory GDP/GTP exchange protein for small GTP-binding proteins. J Biol Chem 1992 Jan 15 12
9 1735612 Regulation of natural antibody binding and susceptibility to natural killer cells through Zn(++)-inducible ras oncogene expression. Int J Cancer 1992 Feb 1 2
10 1756258 Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells. Breast Cancer Res Treat 1991 Aug 1
11 1764089 A peptide from the GAP-binding domain of the ras-p21 protein as well as azatyrosine block ras-induced maturation of Xenopus oocytes. Biochem Biophys Res Commun 1991 Dec 31 1
12 1909512 Preneoplastic transformation in mouse mammary tissue: identification and validation of intermediate biomarkers for chemoprevention. Anticancer Res 1991 May-Jun 4
13 1923528 Activated Val-12 ras p21 in cell culture fluids and mouse plasma. Oncogene 1991 Sep 18
14 2005390 T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes. J Immunol 1991 Mar 15 2
15 2017178 Inhibition of v-src-induced transformation by a GTPase-activating protein. Mol Cell Biol 1991 May 2
16 2118993 Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol Cell Biol 1990 Oct 3
17 2150753 trans-Dominant suppressor mutations of the H-ras oncogene. Cell Growth Differ 1990 May 2
18 2202949 Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13. Oncogene 1990 Aug 1
19 2204019 Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells. Oncogene Res 1990 1
20 2407123 Comparative analysis and anatomic distribution of ras p21, IL-2R, and MEL-14 in malignant and hyperplastic murine thymus. Am J Pathol 1990 Feb 1
21 2428504 Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor. Cell 1986 Sep 26 1
22 2432431 Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorders. Nature 1986 Dec 18-31 1
23 2474786 Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse. Oncogene 1989 Aug 2
24 2480518 Decreased p21 levels in anti-sense ras transfectants augments NK sensitivity. Mol Immunol 1989 Oct 2
25 2541140 Cyclic AMP can partially restore platelet-derived growth factor-stimulated prostaglandin E2 biosynthesis, and calcium mobilization in EJ-ras-transformed NIH-3T3 cells. J Cell Physiol 1989 May 1
26 2543682 Evidence for multiple, ras-like, guanine nucleotide-binding proteins in Swiss 3T3 plasma membranes. Stimulation of GTPase activity by cytosolic factors. J Biol Chem 1989 Jun 25 2
27 2682656 Identification of an intracellular protein that specifically interacts with photoaffinity-labeled oncogenic p21 protein. Proc Natl Acad Sci U S A 1989 Nov 6
28 2695362 Activation of cellular p21ras by myristoylation. Biochem Soc Trans 1989 Oct 1
29 2699569 Growth factor-induced phosphorylation of c-ras p21 in normal hemopoietic progenitor cells. Growth Factors 1989 1
30 2784421 Co-regulation of metastatic and transforming activity of normal and mutant ras genes. Int J Cancer 1989 Mar 15 3
31 2824083 Analysis of the rasH oncogene and its p21 product in chemically induced skin tumors and tumor-derived cell lines. Carcinogenesis 1987 Dec 1
32 2842715 Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems. Oncogene 1988 Aug 6
33 2842717 c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Oncogene 1988 Aug 2
34 2849744 Novel phosphorylation of c-ras p21 by protein kinases. Oncogene Res 1988 7
35 2883654 Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin. Proc Natl Acad Sci U S A 1987 May 1
36 2985821 Development and analysis of a transformation-defective mutant of Harvey murine sarcoma tk virus and its gene product. J Virol 1985 May 6
37 3002353 Differential effects of phorbol ester on the beta-adrenergic response of normal and ras-transformed NIH3T3 cells. Biochem Biophys Res Commun 1985 Dec 17 1
38 3011420 Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities. EMBO J 1986 Apr 7
39 3037340 Microinjection of ras p21 induces a rapid rise in intracellular pH. Mol Cell Biol 1987 May 3
40 3038193 Physiological correlation between nucleoside-diphosphate kinases and the 21-kDa guanine-nucleotide binding proteins copurified with the enzymes from the cell membrane fractions of Ehrlich ascites tumor cells. Biochim Biophys Acta 1987 Jul 29 1
41 3088563 Isolation of ras GTP-binding mutants using an in situ colony-binding assay. Proc Natl Acad Sci U S A 1986 Jul 3
42 3093072 Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells. Cancer Res 1986 Nov 1
43 3097518 rasH mutants deficient in GTP binding. Mol Cell Biol 1986 Sep 1
44 3118192 Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis. Mol Cell Biol 1987 Sep 7
45 3134019 GTP-binding proteins and adenylate cyclase activity in v-Ki-ras transformed NIH/3T3 fibroblast cells. Biochem Biophys Res Commun 1988 Jun 30 2
46 3141783 Characterization of a factor that stimulates hydrolysis of GTP bound to ras gene product p21 (GTPase-activating protein) and correlation of its activity to cell density. Mol Cell Biol 1988 Oct 4
47 3145408 Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 1988 Aug 3
48 3162096 Biochemical properties of a highly purified v-rasH p21 protein overproduced in Escherichia coli and inhibition of its activities by a monoclonal antibody. Mol Cell Biol 1985 Jun 3
49 3494729 Multiple kinases and signal transduction. Phosphorylation of the T cell antigen receptor complex. J Biol Chem 1987 Apr 25 1
50 3520342 Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature 1986 Jun 19-25 1